Lascufloxacin is a novel fluoroquinolone antibiotic used for the treatment of various bacterial infections, particularly those affecting the respiratory tract. To support comprehensive pharmaceutical development… Read more
Lascufloxacin is a novel fluoroquinolone antibiotic used for the treatment of various bacterial infections, particularly those affecting the respiratory tract. To support comprehensive pharmaceutical development and quality control, this category provides high-quality reference standards of the active pharmaceutical ingredient alongside its known impurities. Analytical laboratories utilize these materials for rigorous impurity profiling and method validation, ensuring compliance with regulatory safety standards. This includes the detection of process-related impurities such as N-nitrosolascufloxacin, a specific nitrosamine impurity that requires precise monitoring during synthesis and storage. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification of the drug and its degradation products within complex biological or chemical matrices. By employing these specialized analytical standards, researchers can confirm the identity, purity, and stability of the antibiotic throughout the manufacturing process and in final dosage forms.